BRK-B vs KF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The Korea Fund (KF) presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a massive valuation gap, with the current price ($56.22) trading at a significant discount to its Graham Number ($144.13) and Intrinsic Value ($152.88). The company exhibits an extremely low P/E ratio of 2.57 and a high ROE of 68.15%, suggesting strong profitability relative to its market price. However, these strengths are tempered by a weak current ratio of 0.62 and a bearish technical trend score of 10/100. Despite liquidity concerns and negative operating margins, the sheer magnitude of the undervaluation drives a bullish long-term outlook.
Compare Another Pair
Related Comparisons
BRK-B vs KF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and The Korea Fund, Inc. (KF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.